Prosecution Insights
Last updated: November 12, 2026
Application No. 19/265,241

SAFETY SHIELDS FOR ELONGATED INSTRUMENTS AND RELATED SYSTEMS AND METHODS

Non-Final OA §103§112
Filed
Jul 10, 2025
Priority
Mar 07, 2017 — provisional 62/600,857 +3 more
Examiner
LONG, SARAH A
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Piper Access LLC
OA Round
1 (Non-Final)
61%
Grant Probability
Moderate
1-2
OA Rounds
99%
With Interview

Examiner Intelligence

Grants 61% of resolved cases
61%
Career Allowance Rate
481 granted / 792 resolved
-9.3% vs TC avg
Strong +42% interview lift
Without
With
+42.4%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
53 currently pending
Career history
845
Total Applications
across all art units

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority Applicant’s claim for the benefit of a prior-filed application under 35 U.S.C. 119(e) or under 35 U.S.C. 120, 121, 365(c), or 386(c) is acknowledged. Applicant has not complied with one or more conditions for receiving the benefit of an earlier filing date under 35 U.S.C. 119(e) or under 35 U.S.C. 120, 121, 365(c), or 386(c) as follows: The later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application). The disclosure of the invention in the parent application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) or the first paragraph of pre-AIA 35 U.S.C. 112, except for the best mode requirement. See Transco Products, Inc. v. Performance Contracting, Inc., 38 F.3d 551, 32 USPQ2d 1077 (Fed. Cir. 1994). The disclosure of the prior-filed application, Application No.62/600,857, fails to provide adequate support or enablement in the manner provided by 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph for one or more claims of this application. For example, Application No.62/600,857 fails to disclose “a method comprising: coupling a penetration system to an automated driver…driving the penetration system into a bone via the automated driver to position the cannula within the bone; retracting the elongated instrument in a proximal direction relative to the cannula while the cannula remains positioned within the bone and while the shield remains coupled to each of the cannula hub and the elongated instrument; and automatically locking the shield to the elongated instrument upon further retraction of the elongated instrument.” Accordingly, the present application has an effective filing date of 6/27/2017. Claim Objections Claim 5 is objected to because of the following informalities: Claim 5 recites “the bone penetration system” in line 1 which should read “the penetration system” for consistency purposes. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-6 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 recites the limitation "the shield" in lines 6-7. There is insufficient antecedent basis for this limitation in the claim. Claims 2-6 are rejected based on their dependency to rejected claim 1. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-6 is/are rejected under 35 U.S.C. 103 as being unpatentable over Miller et al. (US 2008/0221580 A1) in view of Blanchard et al. (US 2018/0116693 A1) in view of Burkholz (US 9,399,120 B2). Regarding claims 1-3 and 6, Miller discloses a method comprising: coupling a penetration system (intraosseous device 160) to an automated driver (powered driver 230a; as opening 186 of device 160 is coupled to drive shaft 252 of driver 230a; Figs. 1A, 4A-4B; [0051]), the penetration system (160) comprising: a cannula hub (hub 200; Fig. 4A); a cannula (cannula 210) attached to the cannula hub (200) and defining a lumen (longitudinal passageway 184); an elongated instrument (inner penetrator or stylet 220) positioned within the lumen (184) of the cannula (210; Fig. 4A; [0063]), driving the penetration system (160) into a bone via the automated driver (30) to position the cannula (210) within the bone (as the tip 211 of outer penetrator 210 and/or tip 222 of inner penetrator 220 penetrate bone; [0065]); and retracting the elongated instrument (220) in a proximal direction relative to the cannula (210) while the cannula remains positioned within the bone (as the longitudinal ridges 190 allow connector 180 to be grasped for disengagement from hub 200 of cannula 210 when the outer penetrator 210 has been inserted into a bone and associated bone marrow; [0068]; thus, 180 and 220 thereon are retracted proximally relative to 210 and 200 while 210 is in a bone). Miller fails to disclose a shield coupled to each of the cannula hub and the elongated instrument, the shield defining a distal tip; wherein the shield remains coupled to each of the cannula hub and the elongated instrument while retracting the elongated instrument in the proximal direction relative to the cannula; automatically locking the shield to the elongated instrument upon further retraction of the elongated instrument; automatically disengaging the shield from the cannula hub; wherein said automatically disengaging the shield from the cannula hub and said automatically locking the shield to the elongated instrument occur substantially simultaneously; and wherein the elongated instrument comprises a recess, and wherein said automatically locking the shield to the elongated instrument comprises permitting a portion of the shield to automatically enter into the recess of the elongated instrument. However, Blanchard teaches a method of penetrating a bone (abstract) with a penetration system (intraosseous catheter 20; Figs. 5A-5D) comprising: a cannula hub (hub 42), a cannula (cannula 44) attached to the cannula hub and defining a lumen (Fig. 5C); an elongated instrument (needle/trocar 38) positioned within the lumen of the cannula (Fig. 5C); and a shield (telescoping portion 74) defining a distal tip (Fig. 5D), the shield coupled to each of the cannula hub (42) and the elongated instrument (38; Figs. 5A-5D), the method comprising retracting the elongated instrument (38) in a proximal direction relative to the cannula (44) while the cannula remains positioned within a bone (54, 56; Fig. 5D). Thus, Blanchard teaches a shield for an intraosseous device that prevents an inadvertent needle stick to the user as the elongated instrument is retracted proximally from the cannula ([0036]). Burkholz teaches a shield (inner housing 80; Figs. 7A-7D) for a penetration system (Figs. 7A-7D), the penetration system comprising: a cannula hub (catheter adapter 120); a cannula (cannula surrounding needle 70; Fig. 7A) attached to the Hannula hub (120) and defining a lumen (Fig. 7A); an elongated instrument (needle 40) positioned within the lumen of the cannula (Fig. 7A), the shield (80) defining a distal tip (distal tip of 80), the shield coupled to each of the cannula hub (120) and the elongated instrument (40; Fig. 7A); retracting the elongated instrument (40) in a proximal direction relative to the cannula while the cannula remains positioned distally (Figs. 7A-7D) and while the shield (80) remains coupled to each of the cannula hub (120) and the elongated instrument (40; at least in the position shown in Fig. 7B); and automatically locking the shield (80) to the elongated instrument (40) upon further retraction of the elongated instrument (Figs. 7C-7D). Burkholz teaches automatically disengaging the shield (80) from the cannula hub (120; as transverse barriers, similar to 92 in Figs. 3A-3B close and move away from the inner walls of 120 as they capture a needle tip therein; Figs. 7A-7C); and wherein said automatically disengaging the shield (80) from the cannula hub (120) and said automatically locking the shield (80) to the elongated instrument (40) occur substantially simultaneously (due to closing the transverse barriers; Figs. 7A-7D). Burkholz teaches wherein the elongated instrument (40) comprises a recess (see cutouts near proximal engagement 72; Figs. 7A-7D), and wherein said automatically locking the shield (80) to the elongated instrument (40) comprises permitting a portion (proximal shoulders of 80 within cutouts; Figs. 7C-7D) of the shield (80) to automatically enter into the recess of the elongated instrument (Figs. 7C-7D). Thus, Burkholz teaches a shield similar to that claimed was known in the prior art for covering a sharp tip of a needle. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to modify the penetration system of Miller to include the shield and recess in the elongated instrument as taught by Burkholz in light of the teachings of Banchard, such that the method includes retracting the elongated instrument in a proximal direction relative to the cannula while the cannula remains positioned within the bone and while the shield remains coupled to each of the cannula hub and the elongated instrument; automatically locking the shield to the elongated instrument upon further retraction of the elongated instrument; automatically disengaging the shield from the cannula hub; wherein said automatically disengaging the shield from the cannula hub and said automatically locking the shield to the elongated instrument occur substantially simultaneously; and wherein said automatically locking the shield to the elongated instrument comprises permitting a portion of the shield to automatically enter into the recess of the elongated instrument. Blanchard expresses the need for a shield on an intraosseous device and Burkholz teaches the shield as claimed. Thus, the modification provides a shield for an intraosseous device that prevents an inadvertent needle stick to the user as the elongated instrument is retracted proximally from the cannula ([0036] of Blanchard). Regarding claim 4, Miller modified discloses the invention as claimed above, and Miller further discloses wherein the penetration system (160) further comprises a coupling hub (connector 180) that is coupled to the cannula hub (200; Fig. 4A), and wherein said coupling the penetration system (160) to the automated driver (230a) comprises coupling the coupling hub (180) to the driver (as opening 186 of connector 180 is coupled to drive shaft 252 of driver 230a; Figs. 1A, 4A-4B; [0051]). Regarding claim 5, Miller modified discloses the invention as claimed above, and Miller further discloses wherein said driving the bone penetration system (160) into the bone via the automated driver (230a) comprises rotating the penetration system at a speed of no less than 300 rotations per minute (as the motor and gear assembly are operable to rotate the drive shaft 252 at approximately twelve hundred revolutions per minute; [0014]). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Woehr (US 8,979,802 B2) and Woehr et al. (US 2005/0027263 A1) are noted for teaching shields. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SARAH A LONG whose telephone number is (571)270-3865. The examiner can normally be reached Monday-Friday 9am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at (571)272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SARAH A LONG/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Jul 10, 2025
Application Filed
Sep 08, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12788395
APPARATUS FOR CLOSING A SURGICAL SITE
1y 9m to grant Granted Nov 10, 2026
Patent 12773217
Left Atrial Appendage Clipping Device and Methods for Clipping the LAA
3y 4m to grant Granted Oct 27, 2026
Patent 12773289
ARTICULATED TOOL POSITIONER FOR ROBOTIC SURGERY SYSTEM
2y 0m to grant Granted Oct 27, 2026
Patent 12758256
A NEEDLE LOCK DEVICE AND A NEEDLE GUIDE SYSTEM
2y 0m to grant Granted Oct 13, 2026
Patent 12751825
HEART VALVE PROSTHESIS DELIVERY SYSTEM AND METHOD FOR DELIVERY OF HEART VALVE PROSTHESIS WITH INTRODUCER SHEATH
1y 11m to grant Granted Oct 06, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
61%
Grant Probability
99%
With Interview (+42.4%)
Low
PTA Risk
Based on 792 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month